Sign In
Buy DRIO
$7.50
-0.1000 (-1.32%)
At Close: Jun 05, 2026
DarioHealth Corp. (DRIO) CEO Erez Raphael on Q2 2021 Results - Earnings Call Transcript
02:32pm, Monday, 16'th Aug 2021
DarioHealth Corp. (DRIO) CEO Erez Raphael on Q2 2021 Results - Earnings Call Transcript
Why Is DarioHealth Falling After Earnings?
11:02am, Monday, 16'th Aug 2021
DarioHealth Corp (NASDAQ: DRIO) reported second-quarter FY21 revenue growth of 194% year-on-year to $5.26 million, beating the analyst consensus of $5.11 million. The non-GAAP billings rose 186% Y/
Recap: DarioHealth Q2 Earnings
07:23am, Monday, 16'th Aug 2021
Shares of DarioHealth (NASDAQ:DRIO) fell 0.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were unchanged 0.00% over the past year to ($0.68), whic
DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights
06:40am, Monday, 16'th Aug 2021
NEW YORK, Aug. 16, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provi
DarioHealth Presents New Study Demonstrating Significant Clinical Impact of Personalized Digital Interventions Based on Real-Time Data
08:30am, Thursday, 12'th Aug 2021
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care
DarioHealth Launches Behavioral Health Solutions Globally in New Partnership with Workplace Options
08:30am, Tuesday, 27'th Jul 2021
NEW YORK, July 27, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that
NEW YORK , July 13, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "
New Research from DarioHealth Expands Evidence that Personalized Interventions Impact Health Behaviors and Improve User Engagement
08:30am, Tuesday, 29'th Jun 2021
NEW YORK, June 29, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Assoc
DarioHealth Remote Patient Monitoring Selected by Coastal Family Health Center to Improve Health of Patients with Hypertension
08:30am, Thursday, 24'th Jun 2021
NEW YORK, June 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coasta
DarioHealth Expands Footprint in Musculoskeletal Sensor Technologies with the Upright GO S
08:30am, Wednesday, 16'th Jun 2021
NEW YORK, June 16, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable senso
DarioHealth to be Added to Russell 2000® and 3000® Indexes
08:30am, Tuesday, 15'th Jun 2021
NEW YORK, June 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index
DarioHealth Releases Study Demonstrating the Impact of Personalized Digital Interventions to Improve Self-Management of Diabetes
08:30am, Friday, 04'th Jun 2021
Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a lead
DarioHealth Publishes Research Confirming the Impact of a Digital Therapeutic Platform and Live Coaching on Diabetes Outcomes
08:30am, Thursday, 27'th May 2021
NEW YORK,, May 27, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Ed
DarioHealth to Participate in the Virtual 18th Annual Craig-Hallum Institutional Investor Conference
08:30am, Wednesday, 26'th May 2021
NEW YORK, May 26, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-
DarioHealth Corp. (DRIO) CEO Erez Raphael on Q1 2021 Results - Earnings Call Transcript
04:12pm, Tuesday, 18'th May 2021
DarioHealth Corp. (DRIO) CEO Erez Raphael on Q1 2021 Results - Earnings Call Transcript
